12.5 C
New York

Venture Capital

Elon Musk Learns to Prioritize

So what happened? After spending weeks preparing for a legal battle to avoid buying Twitter, Elon Musk shrugged and said, “OK, I’ll buy it”—at...

Top News

Cellarity’s $121M Raise Signals A Promising Drug Discovery Strategy

Biotech startup Cellarity has raised $121 million in Series C funding, the company said Tuesday. Investors include  Flagship Pioneering (Cellarity’s founding company), Japanese biotech firm...

More Tech IPOs From 2021 Burn Cash Today Than 2019 and 2020 Debuts

If you want more evidence of how much of last year’s IPO market was a bubble, here it is. Nearly two-thirds of tech companies...

More Tech IPOs From 2021 Burn Cash Today Than 2019 and 2020 Debuts

If you want more evidence of how much of last year’s IPO market was a bubble, here it is. Nearly two-thirds of tech companies...

More Tech IPOs From 2021 Burn Cash Today Than 2019 and 2020 Debuts

If you want more evidence of how much of last year’s IPO market was a bubble, here it is. Nearly two-thirds of tech companies...

More Tech IPOs From 2021 Burn Cash Today Than 2019 and 2020 Debuts

If you want more evidence of how much of last year’s IPO market was a bubble, here it is. Nearly two-thirds of tech companies...

The 10 Biggest Rounds Of September: TeraWatt Charges Up Big Round, Biotechs Have Big Month 

This is a monthly feature that runs down the month’s top 10 funding rounds in the U.S. Check out last month’s here. A couple of...
Category Template CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

The 10 Biggest Rounds Of September: TeraWatt Charges Up Big Round, Biotechs Have Big Month 

This is a monthly feature that runs down the month’s top 10 funding rounds in the U.S. Check out last month’s here. A couple of...

AI Is Making Its Way Into Drug Discovery. What Does It Mean For Biotech?

Entrenched in academia, chemist Jacob Berlin spent a decade making small molecules to treat the world’s biggest diseases. He wondered: How can this process...

AI Is Making Its Way Into Drug Discovery. What Does It Mean For Biotech?

Entrenched in academia, chemist Jacob Berlin spent a decade making small molecules to treat the world’s biggest diseases. He wondered: How can this process...

AI Is Making Its Way Into Drug Discovery. What Does It Mean For Biotech?

Entrenched in academia, chemist Jacob Berlin spent a decade making small molecules to treat the world’s biggest diseases. He wondered: How can this process...

The Supply Chain Keeps Eating Venture Capital

A few years ago, if you heard someone talking about supply chains, chances are they actually worked in the logistics space. No more. Ever since...

Vista exits AGDATA after eight years to Levine Leichtman Capital Partners

Levine Leichtman Capital Partners has bought agribusiness workflow and data services provider AGDATA from Vista Equity Partners.The deal comes eight years after Vista picked...
Category Template CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Recent articles

spot_img